Cuba announces advances in cancer treatments

Cuban Researchers from Grupo Empresarial Labiofam advance in the study of natural peptides as a new option for the treatment of cancer, a disease that is now the leading cause of death in Cuba, and one of the main health problems worldwide. Dr. Joseph A. Fraga, director, explained to the press that Cuban specialists have been working with these low density proteins for 15 years. are compounds with great potential, demonstrated through research developed over fifteen years, currently led by a large team of scientists working both in Cuba and in Europe, both in the cloning and sequencing of the substance obtained from natural sources.

Dr. Fraga spoke about the results obtained with a solution of natural peptides for therapy of brain tumors in children, considered the most aggressive in the pediatric population and of the worst prognosis.
On the other hand he stressed that Labiofam has a wide range of products and services that include consulting, marketing of approximately 350 products, such as vaccines, dietary supplements, veterinary biological products, agricultural products and cosmetics. It also provides anti-vectorial and technology transfer assistance.

He indicated that the company seeks opportunities for collaboration and signing agreements with other countries, with the aim of promoting the exchange of knowledge and commercial activities.

Meanwhile, Alexis Diaz, a graduate in Masters in Microbiology and Experimental Pharmacology, referred to the benefits of RjLB-14 peptide, which offers highly effective anti-tumor treatment.

The expert made ​​reference to the fact that it was proven a few years ago the existence of eight peptides in the toxin of a type of Cuban scorpion that had anti- tumor action, but it was decided to prioritize one of them, called RjLB-14, and develop samples via biotechnology to reduce the time to get to the formulation of a remedy.

This entry was posted in Healthcare. Bookmark the permalink.